2022
DOI: 10.1016/j.bioorg.2022.105647
|View full text |Cite
|
Sign up to set email alerts
|

Dimethoxyindoles based thiosemicarbazones as multi-target agents; synthesis, crystal interactions, biological activity and molecular modeling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 26 publications
(12 citation statements)
references
References 74 publications
0
12
0
Order By: Relevance
“…The authors have cited additional references within the Supporting Information. [49][50][51][52][53][54][55][56][57][58][59] The Supporting Information includes all experimental details, characterization data of isolated compounds, and chromatograms of the HPLC and GC analyzes.…”
Section: Supporting Information Summarymentioning
confidence: 99%
“…The authors have cited additional references within the Supporting Information. [49][50][51][52][53][54][55][56][57][58][59] The Supporting Information includes all experimental details, characterization data of isolated compounds, and chromatograms of the HPLC and GC analyzes.…”
Section: Supporting Information Summarymentioning
confidence: 99%
“…Ligands regulate the lipophilicity, solubility, and binding ability of metal complexes to intracellular targets and play a pivotal role in the anticancer activity of metal compounds . A very interesting class of ligands are thiosemicarbazone compounds that are used as metal chelators and have good antitumor activity. Among these, several representative compounds, such as triapine, di-2-pyridinone-4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), and COIT-2, are already in clinical phase I and II studies. Interestingly, thiosemicarbazones show a multimodal action anticancer mechanism after coordination with metal ions, and this provides a new concept for the development of multimodal action anticancer Pt compounds based on thiosemicarbazones. …”
Section: Introductionmentioning
confidence: 99%
“…Thus, it was possible to compare the activity difference between phenylamine and benzylamine. Thiosemicarbazone structure is a pharmacophore group that is frequently used as both AChE and MAO inhibitors 9‐13 . The thiosemicarbazone group was chosen for this significant activity profile.…”
Section: Introductionmentioning
confidence: 99%
“…Thiosemicarbazone structure is a pharmacophore group that is frequently used as both AChE and MAO inhibitors. [9][10][11][12][13] The thiosemicarbazone group was chosen for this significant activity profile. Aromatic and aliphatic structures that can interact with the peripheral anionic region are preferred for the residue of the thiosemicarbazone part.…”
mentioning
confidence: 99%
See 1 more Smart Citation